Malaria experts from countries across Africa met at the 13th Annual National Malaria Control Program (NMCP) Best Practice Sharing Workshop on June 25, 2014. The gathering provided a platform to discuss and share knowledge and experiences and to drive dialogue around improved health outcomes and access to quality antimalarial treatments for patients in Africa. For these workshops, Novartis worked in collaboration with the Global Fund, World Health Organization, the WorldWide Antimalarial Resistance Network, the Kenya Medical Research Institute-Wellcome Trust, Swiss Tropical and Public Health Institute, US Pharmacopeia, Populations Services International, Ifakara Health Institute, and the Pharmacy and Poisons Board.
“It’s crucial that governments take urgent action to ensure patients are not put at risk of substandard treatments. We must make sure that the public is made aware of the importance of taking preventative measures as well. The ongoing role of Novartis in facilitating these workshops provides a platform for discussing these important issues, for sharing best practice in public education, and for mapping the sources of poor quality antimalarials,” said Dr. Ambrose Talisuna, who spoke on behalf of the WorldWide Antimalarial Resistance Network.